TD Cowen raises Cardinal Health price target to $275

0 min read Updated on 10 Jul 2026, 12:49 AM

Reviewed by

Radhika SScanX News Team

AI Summary

TD Cowen analyst Charles Rhyee maintained a Buy rating on Cardinal Health and raised the price target to $275 from $255.

*this image is generated using AI for illustrative purposes only.

TD Cowen analyst Charles Rhyee has maintained a Buy rating on Cardinal Health (NYSE: CAH) and raised the price target to $275 from the previous $255.

The adjustment reflects an updated valuation outlook for the healthcare services company. Cardinal Health operates as a distributor of pharmaceuticals and medical products.

Rating and Price Target Details

The following table outlines the revised ratings and price targets:

Metric	Value
Rating	Buy
Previous Price Target	$255
New Price Target	$275

What specific factors drove the updated valuation outlook for Cardinal Health?

How might the current pharmaceutical distribution landscape impact Cardinal Health's growth trajectory?

What are the potential risks or challenges that could affect the achievement of the new $275 price target?

Read Next Article

Cardinal Health to announce FY26 results on August 11

0 min read Updated on 09 Jul 2026, 04:46 PM

Reviewed by

Naman SScanX News Team

Add as a preferred
source on Google

AI Summary

Cardinal Health will release its fourth-quarter and fiscal year 2026 financial results on August 11 before the market opens. A webcast to discuss the results will begin at 8:30 a.m. Eastern, accessible via the company's Investor Relations page. Presentation slides and a replay will be available for 12 months.

*this image is generated using AI for illustrative purposes only.

Cardinal Health plans to release its fourth-quarter and fiscal year 2026 financial results on August 11, prior to the opening of trading on the New York Stock Exchange. The announcement will provide insights into the company's performance for the final quarter and the full fiscal year. A webcast to discuss these results is scheduled to begin at 8:30 a.m. Eastern.

Investors and stakeholders can access the live webcast and the corresponding slide presentation through Cardinal Health's Investor Relations page. No access code is required to view the broadcast. Following the event, the presentation slides and a webcast replay will remain accessible on the Investor Relations page for 12 months.

Key Event Details

Event	Date	Time
Financial Results Release	August 11	Before market open
Investor Webcast	August 11	8:30 a.m. Eastern

Cardinal Health operates as a distributor of pharmaceuticals and specialty products, a supplier of home-health and direct-to-patient products and services, and a global manufacturer and distributor of medical and laboratory products. The company also provides performance and data solutions and operates nuclear pharmacies and manufacturing facilities.

What strategic initiatives will Cardinal Health highlight to drive growth in fiscal year 2027?

How might the financial results impact Cardinal Health's stock performance and investor sentiment?

What challenges or opportunities in the pharmaceutical and medical products distribution sectors could influence future earnings?